SOX9 and cholangiocarcinoma: To explore the involvement of DNMT1 in the Sox9-mediated reduction in AY/AN-cHCC-CCA, we delivered a plasmid expressing full-length Dnmt1 into Sox9 CKO mice to investigate its association with SOX9 during liver cancer development.